Schmallenberg virus (SBV) causes abortions, stillbirths and fetal malformations in naïve ruminants. The impact of the initial outbreak (2011/2012) on British sheep farms has been previously investigated, with higher farmer perceived impacts and increased lamb and ewe mortality reported on SBV-affected farms. After several years of low, or no, circulation the UK sheep flock once again became vulnerable to SBV infection. Re-emergence was confirmed in autumn 2016. This study reports the analysis of a questionnaire designed to determine the farm-level impact of SBV on the 2016/2017 UK lambing period. Higher neonatal lamb mortality, dystocia and associated ewe deaths, and higher perceived impacts on sheep welfare, flock financial performance and farmer emotional wellness were reported on SBV confirmed (n=59) and SBV suspected (n=82), than SBV not suspected (n=74) farms. Additionally, although few farmers (20.4 per cent) reported previously vaccinating against SBV, the majority (78.3 per cent) stated they would vaccinate if purchasing at less than £1 per dose. These results are largely comparable to the findings reported for the 2011/2012 outbreak, highlighting the ongoing impact of SBV on sheep farms. If SBV continues to re-emerge cyclically, the economic and animal welfare costs to the UK sheep farming industry will continue.
- schmallenberg virus
- disease impact
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Schmallenberg virus (SBV) is a teratogenic virus, transmitted by Culicoides biting midges, that infects ruminants.1–3 The first reports of SBV came from Germany and the Netherlands in autumn 2011 where cattle presenting with diarrhoea, febrile episodes and a reduced milk yield tested negative for all known bovine pathogens. Following this initial description, reports of SBV quickly emerged throughout Europe, with transmission facilitated by the dispersal of the Culicoides vectors by wind and a completely naïve host population.4
Infections of adult ruminants are typically asymptomatic, or present with only mild clinical signs, as observed in cattle.5–7 However, if a naïve animal is infected for the first time during the vulnerable period of gestation, infection can result in stillbirths and fetal abnormalities, including arthrogryposis and hydranencephaly.8 Infection early in pregnancy has also been linked to lower conception rates, abortions and reduction in weaning rates.9–12 These associated clinical signs of disease are particularly problematic for block breeding production systems, with high reported losses from the disease in early lambing sheep flocks in 2011/2012.10 13–15
Farm-level disease incidence is known to vary significantly, as does the resulting impact. The UK Animal and Plant Health Agency (APHA) found 6 per cent of farmers from SBV confirmed or SBV suspected farms were less likely to farm sheep again the next year, compared with only 1.8 per cent of farmers from farms unaffected by SBV in the initial outbreak.16 Economic costs may also be higher than originally considered due to the difficulties in quantifying certain types of losses. For example, higher barren rates and reduced fertility are reported in some studies.10 12 17 Furthermore, due to the associated deformities, dystocia is relatively common, potentially resulting in additional losses of ewes while birthing malformed lambs.3 Critically, all studies estimating the impact of SBV have acknowledged the issue of under-reporting; SBV is not a listed notifiable disease by the World Organisation for Animal Health, with farmers from many member states of the EU voluntarily submitting samples and paying for confirmation testing and therefore accurate estimates of the true impact of disease are hard to establish.14 18
The unpredictable and intermittent nature of SBV has impacted on farmer uptake of vaccination; the main effective control measure. Having circulated and successfully overwintered between the 2011/2012 and 2012/2013 lambing seasons, SBV reports in the UK reduced dramatically in 2014. Several studies in Europe described very low circulation between 2014 and 2015.19–21 These studies highlighted large SBV-naïve populations vulnerable to reinfection, particularly as time progressed and vaccinations became no longer available.
After three years of low SBV circulation SBV re-emerged in Europe; by December 2016 deformed lambs were confirmed positive for SBV in the UK.22 With the vaccines withdrawn from the market due to poor uptake, and the duration of natural immunity unknown, the UK national flock was likely to be susceptible to infection.
This study aimed to measure and compare the impact of the 2016/2017 re-emergence of SBV on sheep flocks in the UK with the impact reported during the initial 2011/2012 outbreak. Expanding on a study following the initial outbreak,16 a questionnaire was designed to determine the impact of SBV during the 2016/2017 lambing period on lamb and ewe losses, farmer perceived emotional, financial and welfare costs and views on vaccination.16
Materials and methods
To directly compare the impact of SBV on the 2016/2017 lambing season with that reported in 2011/2012 a questionnaire was designed to closely match that of Harris and others.16 Additional questions were designed by the authors. The questionnaire was tested by four sheep farmers and feedback incorporated into the final questionnaire (online supplementary information). Questionnaire participation was voluntary and open to all UK sheep farmers. The final version was launched online on March 24, 2017 using SurveyMonkey (California, USA). The online questionnaire was publicised periodically through Twitter, with support from AHDB Beef and Lamb, Sheep Veterinary Society and the APHA. A link to the online questionnaire was also handed out by veterinary students from both universities while on Easter lambing placements. A further 250 questionnaires were sent out by the APHA to farmers who had submitted samples for SBV testing in England and Wales on June 1, 2017.
A total of 32 questions were asked to determine farm demographics, lambing productivity and mortality, ewe mortality, vaccination history, the farms’ SBV status and farmers’ perception towards the impact of SBV on flock welfare, financial performance and the farmers’ own emotional wellbeing. The farms’ SBV status was determined by responses to two questions within the questionnaire and coauthors’ opinions of additional comments. The categories were:
SBV confirmed: Farms where a suspected lamb was confirmed positive for SBV by laboratory testing (at the time of the study the APHA were offering the RT-PCR testing of cerebral cortex or fresh brainstem from lambs).
SBV suspected: SBV was suspected by the farmer or their veterinarian. This includes farms that had positive testing of ewe blood samples for ELISA serology, and those that had lambs sent off for laboratory testing (with relevant clinical signs) that were not confirmed positive.
SBV not suspected (by respondent): No report of suspected SBV (based on a lack of farmer observed clinical signs) and did not send off any samples for SBV testing.
All online results were downloaded from SurveyMonkey on June 19, 2017. All paper versions were manually entered to create a master copy. Responses were checked for consistency, any insufficiently completed responses were removed from the working copy.
To allow direct comparison to the previous 2011/2012 study16 the same calculations and definitions were applied, briefly:
Lamb mortality (%)=100*(lambs dead from any cause within one week/total lambs born)
Lambing mortality (%)=100*(lambs dead from any cause within one week/non-barren ewes)
Ewe mortality (%)=100*(number of ewes that died during lambing/non-barren ewes)
Responses for farm demography, lambing productivity, lamb mortality, ewe mortality and the farmers’ impact perception questions were compared across SBV categories. All maps were created in QGIS V.2.2.0 and all statistical analyses were completed in R, V.220.127.116.11 24 Analysis of variance (ANOVA) and Tukey’s honestly significant difference post hoc tests were used to compare differences across the SBV categories for continuous data. If the Levene’s test for homogeneity of variance was significant the alternative Welch test was used with a Games-Howell post hoc test. For categorical data and vaccination history, Pearson’s χ2 tests were completed. Where the assumptions of the χ2 were violated a Fisher’s exact test was used.
Farmers were asked to describe any malformations seen in lambs on farm, regardless of SBV status. These descriptions were then coded separately by the authors (JES, RET and JSD) into five groups previously described16 and ‘Other’. Themes resulting from the ‘Other’ group created two more groups: fused joints and eye-related deformities. The coding was undertaken blind and SBV category masked to reduce the possibility of bias. The coded results were then combined; those that did not match exactly (n=33) were reviewed and a consensus reached between authors.
In total, 318 respondents participated in the survey, 232 online and 86 via post (postal response rate 34.4 per cent). All 86 postal responses were included in the survey; however, only 129 of the online responses were completed in sufficient detail to be included, leaving 215 useable responses. Not all participants answered every question.
The majority of respondents were from the west of England and Wales (n=214, 65.0 per cent). In total, 27.4 per cent of respondents were from SBV confirmed farms, 38.1 per cent from SBV suspected farms and 34.4 per cent from SBV not suspected farms (n=215) (figure 1). Flock types did not significantly differ in SBV categories (P=0.17, table 1) with a total of 56.5 per cent of respondents defining their flock as crossbreeds/commercial animals. There was a non-significant trend towards a difference between the SBV categories of the two farm types (P=0.07, table 1): specifically, there was a greater proportion of upland/hill farms in the SBV not suspected category than lowland farms.
Breeding seasons, scanning rates and lambing percentages
The earliest reported date for the ram to be put in with the ewes was the May 18, 2016; the latest date of ram removal was April 16, 2017. The reported duration of the mating season was similar, but slightly shorter for SBV not suspected farms when compared with confirmed and suspected farms (table 2).
The start dates for mating were grouped into four categories: ‘May/June’ (spring/early summer), ‘July/August’ (mid-summer), ‘September/October’ (early autumn) and ‘November/December’ (late autumn/winter) to allow comparison by SBV category for different seasonal mating strategies. There was a significant difference between the mating start dates on SBV confirmed and SBV suspected farms compared with SBV not suspected farms (P<0.001; post hoc test with Bonferroni’s correction P<0.001) with earlier mating start dates reported on SBV confirmed and SBV suspected farms (figure 2).
The median duration of lambing season was significantly different across the categories, with SBV not suspected farms recording a median lambing duration of 24.5 days less than SBV confirmed farms (P<0.001, table 2).
There was no significant difference between the SBV categories and barren rates, scanning percentages or lambing percentages (table 2).
Significantly higher lamb mortality was observed on SBV confirmed farms (median of 9.1 lamb deaths per 100 born) and SBV suspected farms (median of 7.6 per cent) than on SBV not suspected farms (median of 5.7 per cent) (P<0.001, table 3).
Lambing mortality was also significantly higher on SBV confirmed farms (median of 15.2 lamb deaths per 100 pregnant ewes) than SBV suspected (median 12.7 per cent) or SBV not suspected farms (median 8.4 per cent) (P<0.001, table 3).
Particularly high lambing mortality (more than 40 per cent lambing mortality) was observed more frequently on SBV confirmed farms (13.8 per cent) and SBV suspected farms (8.3 per cent) than on SBV not suspected farms (3.2 per cent). Far more outliers were observed for SBV confirmed farms than SBV not suspected farms (figure 3).
Abnormalities in lambs
A greater number of malformations were reported by SBV suspected than SBV confirmed or SBV not suspected farms. Twisted limbs were the most frequently reported malformation on SBV confirmed and SBV suspected farms, a curved back was the most frequently reported malformation on SBV not suspected farms (figure 4). The most common reported eye deformities on SBV confirmed and suspected farms (n=9) were a lack of eyes (three and two reports, respectively) and blindness (one and two reports, respectively). One farmer who did not suspect SBV on farm also reported a lack of eyes on one lamb.
At least one malformation was described by 84.7 per cent (50/59) of SBV confirmed farms, 87.8 per cent (72/82) of SBV suspected farms and 31.1 per cent (23/74) of SBV not suspected farms.
Ewe mortality during the lambing period was not significantly different across the SBV categories; however, the number of ewes that died while giving birth to a deformed lamb was significantly different between the groups (P=0.011). In total, 30.9 per cent (n=17) respondents from SBV confirmed farms reported one or more ewe deaths due to birthing a malformed lamb, similarly 26.4 per cent (n=19) reported the same for SBV suspected farms, while only 5.6 per cent (n=3) of respondents on SBV not suspected farms reported any ewe deaths due to birthing malformed lambs (table 4).
The difference in the number of caesarean sections between categories was significant (P=0.008), with 32.6 per cent (n=15) of respondents on SBV confirmed farms reporting one or more caesarean sections due to birthing a deformed lamb, 24.5 per cent (n=12) of respondents reporting the same on SBV suspected farms, compared with no caesareans due to birthing deformed lambs on SBV not suspected farms (table 4).
There was also a significant difference (P<0.001) between the number of respondents reporting farmer assistance of one or more ewes during lambing due to birthing a deformed lamb; 80 per cent (n=32) on SBV confirmed farms, 78.2 per cent (n=43) on SBV suspected farms and only 33.3 per cent (n=9) on SBV not suspected farms (table 4).
Farmer perceived impacts
There was a significant difference between SBV category responses to the farmer perceived impact of SBV on the welfare of the flock, financial performance of the flock and farmers’ emotional wellbeing (P<0.001) (table 5).
In total, 10.2 per cent of farmers on SBV confirmed farms and 3.7 per cent of farmers on SBV suspected farms reported that they were less likely to farm sheep again next year because of SBV. No farmer reported being less likely to farm sheep again next year because of SBV from SBV not suspected farms (table 5).
There was no significant difference between SBV category and reported vaccination history (P=0.558). The majority of respondents had never previously vaccinated against SBV (79.6 per cent), with the most reported vaccinations against SBV occurring in 2013 (13.3 per cent) (figure 5).
Current demand for vaccination
There was a small significant difference between the SBV categories and the price they would be willing to pay to vaccinate now against SBV (P=0.046). A higher proportion of respondents from SBV not suspected farms stated they would not vaccinate than respondents from SBV confirmed or SBV suspected farms (table 6). Roughly a third of respondents from SBV confirmed and SBV suspected farms stated they would consider vaccinating now if the vaccine costs less than £1, whereas just over a quarter of respondents from SBV not suspected farms would do the same.
This study has investigated the farm-level impact of SBV re-emergence on the 2016/2017 lambing season in the UK, allowing for comparisons to the initial 2011/2012 impact study by utilising the same methodology.16 Both this study and the original are limited by the reliance on farmer self-reporting of disease status rather than targeted testing. This survey focused on the impacts of the virus on lamb deformities, subsequent lambing problems and mortality events rather than monitoring for the effects of infection of adults outside of the susceptible period of gestation for deformities. SBV is not a notifiable disease in the UK, meaning that national-level systematic surveillance data are not available. It seems likely that most flocks were exposed to SBV in 2016/2017 as positive diagnostic submissions were reported across most areas of England, Wales and Southern Scotland.22 The respondents within this survey may be considered typical of the UK sheep farming community, as distribution of farm responses reflects the known density of sheep holdings in England and Wales, the respondents represented a range of farm sizes (from 3 to 3500 breeding ewes) and all major types of sheep farm were represented (hill, lowland, upland, pedigree and commercial farms).25 26 Therefore, in the absence of national disease prevalence data, the study can be considered a useful source of information on the farmer perceived, farm-level impact of SBV in the UK in 2016/2017 and allows comparison with the impact of the initial 2011/2012 outbreak.
As these survey data are farmer reported, there is the potential for reporting and recall bias. To address this possibility the categorisation of respondents into ‘SBV confirmed’, ‘SBV suspected’ and ‘SBV not suspected’ was highly conservative. Only respondents reporting cases on farm confirmed by the laboratory testing of a lamb were included in ‘SBV confirmed’, to ensure only RT-PCR confirmed cases were included in this grouping. All confirmed antibody serological testing of adult stock (ELISA and virus neutralisation test) was considered ‘suspected’, as it would be impossible to rule out historic antibodies, indicating exposure prior to the 2016/2017 outbreak. Only farmers answering ‘No’ and confirming no laboratory testing had been undertaken were designated ‘SBV not suspected’. False negatives in testing of lambs cannot be ruled out as this is a known issue with SBV testing.27 It is also very likely that many of the ‘SBV not suspected’ farms have had animals seroconvert (possibly outside of the period of pregnancy where malformations would be a risk) but as they had not seen the typical deformities and not tested for the virus were unaware of this. Similarly, false positives in the ‘suspected’ category may have occurred as not all congenital lamb malformations are due to SBV.
The significant difference observed between the SBV categories for lamb abnormalities provides justification for the current groupings, as if these were poorly differentiated then no observed differences in abnormalities would be seen. The fact that the SBV confirmed farms in general lambed earlier (and therefore would have had animals in the susceptible stages of pregnancy when the virus is thought to have circulated) when compared with the ‘not suspected’ group which generally lambed later and outside of this window also provides support for the current groupings.
In the present study the effects of SBV, reported by farmers, were increased neonatal lamb mortality, lambing mortality, dystocia and associated ewe deaths. In addition, farmers from SBV confirmed and suspected farms perceived that SBV had a significant negative impact on sheep welfare, the farms’ financial performance and their own emotional wellbeing. Farmers whose flocks were affected by SBV reported that they were less likely to farm again next year. Importantly, SBV confirmed and SBV suspected farms in this study typically described an earlier mating period than SBV not suspected farms, providing supportive evidence for the suggested period of disease re-emergence in the UK. The findings of the impact of the 2016/2017 SBV outbreak on sheep farms reported in the present study are largely comparable to the findings reported in the 2011/2012 outbreak, with the exception of ewe mortality. A comparative summary of results is presented in table 7 and is discussed below.
Mating start dates and lambing season duration were found to be significantly different between the SBV categories. Importantly, SBV confirmed and SBV suspected farms typically started mating in July/August (61 and 44 per cent, respectively), whereas the majority of SBV not suspected farms (69 per cent) reported mating in September/October; this would put the vulnerable period of gestation for fetal deformities (approximately days 28–56 of pregnancy) for these later mated flocks largely outside of the autumn activity peak of the SBV Culicoides vector species.18 28 As SBV was determined to have circulated in Culicoides in August 2016 in Belgium,29 and due to confirmed SBV malformations in lambs in south England beginning in December, peaking across England in January and February 2017,22 it is likely that SBV circulated widely in England in September/October 2016.22 29 This is further supported by unpublished data from the University of Nottingham flock, demonstrating seroconversion to SBV and viral RNA in October 2016. This timing of circulation agrees with the results of this study: that those worst affected by fetal malformations were flocks mating in August/September 2016.
Questions have been raised regarding the impact of SBV on early reproductive losses in sheep flocks.17 However, in the present study there was no difference in the reported barren ewe rate between SBV categories, nor was a difference reported in the previous 2011/2012 study. Indeed, the reported median barren rates in this study (3.7 per cent) were very similar to those reported for the 2011/2012 outbreak (4 per cent)16 and although these barren ewe rates are higher than industry guidelines,30 they appear to be typical of UK sheep flocks.25 31 A study on SBV infection and early ewe reproductive performance in the Netherlands also failed to find associations.10
The lamb mortality and lambing mortality were significantly higher on SBV confirmed and SBV suspected farms, with almost double the median lamb mortality and lambing mortality on SBV confirmed farms (median 15.2 and 9.1 per cent, respectively) compared with SBV not suspected farms (median 8.4 and 5.7 per cent, respectively). These results were very similar to those reported in the UK during 2011/2012 lambing and in European studies.10 11 13 16 17 The lamb mortality on SBV not suspected farms reported here was comparable to industry figures and studies of lamb mortality in UK flocks, prior to the 2011 SBV outbreak.25 32
Increased lamb mortality observed on SBV affected farms is likely an effect of the associated congenital malformations and behavioural abnormalities on the lamb’s ability to adapt to postnatal life. Several congenital malformations were associated with SBV infection in the present study. Twisted limbs were the most frequently reported malformation of lambs on SBV confirmed and SBV suspected farms, followed by curved backs and deformed heads. This agrees with the previous UK experience of SBV. Several farmers reported eye deformities, including blindness; previously reported by farmers in the 2012/2013 study and in an SBV clinical investigation of a calf.16 33 Some farms in the not suspected category did have lambs with deformities that could be consistent with SBV, though at a very much lower rate than the SBV farms. Some of these may have been assumed to be due to teratogens like Border disease that farmers are more familiar with in the UK and that can produce similar deformities. This highlights the need for testing as congenital malformations in lambs are not exclusive to SBV infection and can be the result of a wide range of teratogenic, genetic or nutritional factors.34 This also helps to prevent the assumption that all malformations are SBV, ensuring the cause is properly investigated and diagnosed. The data from such testing also provide passive surveillance, which can act as an alert for an increase in viral circulation or reduction in national flock immunity to SBV.
Overall there was no difference in ewe mortality across SBV categories in the present study. Although unsurprisingly, both ewe mortality associated with birthing malformed lambs and the number of assisted births (both by the farmer and by caesarean) were greater on SBV affected farms. More caesarean sections were also reported on SBV confirmed and SBV suspected farms in this study (33 and 25 per cent, respectively) than reported during the initial 2011/2012 outbreak (12 and 11 per cent, respectively).16 Certainly the delivery of malformed lambs presents increased risk to ewe health, although there was no evidence for an impact on overall ewe mortality as previously reported.16 This could be due to improved farmer/veterinary awareness of the risk to ewe health, and therefore earlier appropriate obstetrical intervention.
As expected the perceived welfare, economic and emotional impact of SBV to farmers was generally high on SBV confirmed and suspected farms, and low on SBV not suspected farms. The greatest reported negative impact was on farmers’ emotional wellbeing. As SBV is no longer novel, the distressing nature of the associated malformations is well known among farming communities. It is likely that this awareness, along with potential previous experience of the disease, is likely to have contributed to the high proportion of negative emotional impact of SBV reported, even on unaffected farms. A total of 4.3 per cent respondents stated they were less likely to sheep farm next year because of SBV. This is comparable to the proportion of respondents stating the same after the previous SBV outbreak (3.7 per cent).16
Although the data do not provide a complete description of the 2016/2017 UK outbreak, it is interesting that the geographic distribution of SBV confirmed farms in this sample did deviate from the previous 2011/2012 outbreak distribution. In 2011/2012 the outbreak began in south-east England and rapidly spread in a north-westerly direction covering the majority of England and Wales to the Scottish Border.35 Here, despite the survey being distributed nationally, the majority of SBV positive farms were in the west of England and Wales. Perhaps the difference in response distribution between the surveys reflects a different route or timing of disease introduction between the 2011/2012 and 2016/2017 outbreaks.22
Vaccination history against SBV was also explored. Only one-fifth (20.2 per cent) of respondents stated they had vaccinated against SBV previously; however, over 78 per cent of respondents stated they would consider paying to vaccinate against SBV if the vaccine was available. Interestingly, more respondents from SBV confirmed farms stated they had vaccinated in 2013 than SBV suspected or SBV not suspected farms. It may be the farm management practices place them at higher risk of SBV and therefore they are more conscious of disease risk and more likely to vaccinate.
Under-reporting of SBV cases is recognised as an issue for measuring the impact of the disease on populations.14 The number of suspected cases in this study that were not sent off for testing, in areas where confirmed positives existed, also highlights the potential extent of under-reporting. Surveys such as this represent the only way to estimate the potential extent of impact on farm of non-notifiable diseases. Although many farmers would send off a single suspected case for testing, it would be unusual, due to the upfront and time costs of testing during an extremely busy period for sheep farms (lambing), to send off all suspected cases on farm for confirmatory testing.14 Additionally, as infection of adult ruminants is typically asymptomatic it is likely that infection occurred on many unsuspecting farms, just outside of the vulnerable period of gestation for deformities. This may account for why no significant differences were observed between SBV categories and early oestrus factors such as barren rates, lambing percentages and scanning percentages.
The results of this survey clearly demonstrate an impact of SBV on the 2016/2017 lambing season, comparable to that reported for the 2011/2012 lambing season.16 If SBV transmission continues to be cyclical in nature, the associated animal welfare and subsequent economic costs to the UK sheep farming industry will continue every few years if intervention is not taken. Controlling the Culicoides vector has so far been unfeasible, subsequently the importance of timely vaccination (if available) or coinciding mating with colder periods will continue to be necessary to reduce the impact of future SBV outbreaks. National surveillance programmes, particularly collaborative surveillance programmes with European member states, are increasingly important for the application of timely vaccination programmes; however, vaccination production ceases when demand is low. Future studies should aim to address this cyclical epidemiology, particularly identifying where the virus persists between outbreaks to allow the development of predictive early-warning models.
The authors extend their gratitude to K Harris and others for granting permission to replicate several questions from the original study. The authors particularly thank all farmers who participated in the study.
Funding This study was funded by the Biotechnology and Biological Sciences Research Council (grant number BB/M011186/1).
Competing interests None declared.
Ethics approval This study was reviewed and approved by the University of Liverpool internal ethics committee (VREC537).
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.